Effect of indoxyl sulfate on hepcidin regulation
Hamano, Hirofumi Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Ikeda, Yasumasa Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Watanabe, Hiroaki Tokushima University
Horinouchi, Yuya Tokushima University
Izawa-Ishizawa, Yuki Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Imanishi, Masaki Tokushima University Tokushima University Educator and Researcher Directory
Takechi, Kenshi Tokushima University
Ishizawa, Keisuke Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Tsuchiya, Koichiro Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
chronic kidney disease
Thesis or Dissertation
Background: Hepcidin secreted by hepatocytes is a key regulator of iron metabolism throughout the body. Hepcidin concentrations are increased in chronic kidney disease (CKD), contributing to abnormalities in iron metabolism. Levels of indoxyl sulfate (IS), a uremic toxin, are also elevated in CKD. However, the effect of IS accumulation on iron metabolism remains unclear.
Methods: We used HepG2 cells to determine the mechanism by which IS regulates hepcidin concentrations. We also used a mouse model of adenine-induced CKD. The CKD mice were divided into two groups: one was treated using AST-120 and the other received no treatment. We examined control mice, CKD mice, CKD mice treated using AST-120, and mice treated with IS via drinking water.
Results: In the in vitro experiments using HepG2 cells, IS increased hepcidin expression in a dose-dependent manner. Silencing of the aryl hydrocarbon receptor (AhR) inhibited IS-induced hepcidin expression. Furthermore, IS induced oxidative stress, and antioxidant drugs diminished IS-induced hepcidin expression. Adenine-induced CKD mice demonstrated an increase in hepcidin concentrations; this increase was reduced by AST-120, an oral adsorbent of the uremic toxin. CKD mice showed renal anemia, decreased plasma iron concentration, increased plasma ferritin, and increased iron content in the spleen. Ferroportin was decreased in the duodenum and increased in the spleen. These changes were ameliorated by AST-120 treatment. Mice treated by direct IS administration showed hepatic hepcidin upregulation.
Conclusion: IS affects iron metabolism in CKD by participating in hepcidin regulation via pathways that depend on AhR and oxidative stress.
Nephrology Dialysis Transplantation
Oxford University Press
This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology Dialysis Transplantation following peer review. The version of record, Nephrology Dialysis Transplantation (2017) Article ID: gfx252 is available online at: https://doi.org/10.1093/ndt/gfx252.
|DOI (Published Version)|
|URL ( Publisher's Version )|
k3101_abstract_review.pdf 324 KB
k3101_fulltext.pdf 553 KB
|MEXT report number||
Doctor of Medical Science